Altered hippocampal doublecortin expression in Parkinson's disease

Area of Science:

• Neuroscience
• Cell Biology
• Neurodegenerative Diseases

Background:

• Parkinson's disease (PD) presents with motor and non-motor symptoms, some potentially linked to hippocampal function.
• Adult hippocampal neurogenesis, the birth of new neurons in the hippocampus, may be affected in PD.
• Doublecortin (DCX) is a key protein marker for immature, migrating neurons.

Purpose of the Study:

• To investigate the role of Doublecortin (DCX) expression in adult hippocampal neurogenesis in Parkinson's disease (PD).
• To examine potential alterations in neurogenesis markers in postmortem brain tissue of PD patients compared to controls.

Main Methods:

• Utilized postmortem human brain tissue from PD patients and age-matched controls.
• Quantified the number and nuclear area of Doublecortin (DCX)-expressing cells in the subgranular zone (SGZ) of the hippocampus.
• Assessed the correlation between DCX-positive cell nuclear area and pH levels.

Main Results:

• Found a significant reduction in the number of DCX-expressing cells in the SGZ of PD brains.
• Observed a decreased nuclear area in DCX-positive cells in PD cases.
• Correlated the nuclear area of DCX-positive cells with pH levels, suggesting a link to cellular environment.

Conclusions:

• Adult hippocampal neurogenesis appears to be compromised in Parkinson's disease (PD).
• Reduced DCX expression and altered cell morphology suggest impaired neurogenesis in PD.
• These findings offer insights into the pathophysiology of PD-related neuropsychiatric symptoms and potential therapeutic targets.